The Life Sciences team advised Acino on its agreement to acquire M8 Pharmaceuticals.
Through this acquisition, Acino will enter the two largest pharmaceutical markets in Latin America, significantly expanding its geographic footprint and strengthening its position in the region, providing a more powerful and comprehensive offering for healthcare professionals and patients.
Acino is a Swiss pharmaceutical company headquartered in Zurich with focused on selected markets in the Middle East, Africa, Ukraine, and Latin America.
M8 is a specialty biopharmaceutical company focused on licensing, marketing and distributing innovative and established therapeutics in Brazil and Mexico.
The Goodwin team was led by Robert Masella and Yasin Akbari, and the team included Grace Wirth, Daniel Karelitz, Jacob Osborn, Paul Jin, Srikanth Reddy, Samuel Beavers, Larissa Pinho, Daniela Sanchez, Cecelia Lockner, Kevin Walsh, Jonathan Elefant, Gozde Guckaya, Carrie Miller, Xiaowei Wu, Benjamin Kurrass, Nicole Brock, Jennifer Ford, Ana Alvarado and Brad Smith.
For more details, read the press release.